{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:44:29Z","timestamp":1785887069939,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032443","name":"Hong Kong Jockey Club","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["CID-HKU-2-20"],"award-info":[{"award-number":["CID-HKU-2-20"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022720","name":"Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-067155"],"award-info":[{"award-number":["INV-067155"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lanwpc.2026.101892","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:25:48Z","timestamp":1781724348000},"page":"101892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness and health impact of gender-neutral and single-dose HPV vaccination in Hong Kong: a modeling analysis"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-8780","authenticated-orcid":false,"given":"Horace Cheuk Wai","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4777-388X","authenticated-orcid":false,"given":"Kathy","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3155-5987","authenticated-orcid":false,"given":"Joseph T","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lanwpc.2026.101892_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101892_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"de Sanjose","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101892_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8030391","article-title":"Human papillomavirus vaccines: an updated review","volume":"8","author":"Cheng","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.lanwpc.2026.101892_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.puhe.2021.05.012","article-title":"The efficacy of vaccination to prevent human papilloma viruses infection at anal and oral: a systematic review and meta-analysis","volume":"196","author":"Zhang","year":"2021","journal-title":"Public Health"},{"issue":"50","key":"10.1016\/j.lanwpc.2026.101892_bib5","first-page":"645","article-title":"Human papillomavirus vaccines WHO position paper","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanwpc.2026.101892_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12916-018-1118-3","article-title":"Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis","volume":"16","author":"Choi","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010226","article-title":"Changes in the incidence and human papillomavirus-positive portion of oropharyngeal squamous cell carcinoma in Hong Kong","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv282","article-title":"Health and economic impact of switching from a 4-valent to a 9-valent HPV vaccination program in the United States","volume":"108","author":"Brisson","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05632-0","article-title":"Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study","volume":"21","author":"Cody","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanwpc.2026.101892_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcv.2008.11.001","article-title":"Distribution of human papillomavirus types in anogenital warts of men","volume":"44","author":"Chan","year":"2009","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101892_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003534","article-title":"Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: a cost-effectiveness analysis","volume":"18","author":"Kim","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanwpc.2026.101892_bib19","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/jmv.21575","article-title":"Epidemiologic risk profile of infection with different groups of human papillomaviruses","volume":"81","author":"Chan","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.lanwpc.2026.101892_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2334-10-272","article-title":"Incidence of genital warts among the Hong Kong general adult population","volume":"10","author":"Lin","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.lanwpc.2026.101892_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101892_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"Malagon","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.lanwpc.2026.101892_bib23","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.vaccine.2018.03.057","article-title":"Parental acceptability of HPV vaccination for boys and girls aged 9-13 years in China - a population-based study","volume":"36","author":"Wang","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101892_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198615","article-title":"Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong","volume":"13","author":"Cheung","year":"2018","journal-title":"PLoS One"},{"issue":"67","key":"10.1016\/j.lanwpc.2026.101892_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jncimonographs\/lgae042","article-title":"A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination","volume":"2024","author":"Malvi","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"67","key":"10.1016\/j.lanwpc.2026.101892_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jncimonographs\/lgae032","article-title":"HPV16\/18 antibodies 16-years after single dose of bivalent HPV vaccination: costa Rica HPV vaccine trial","volume":"2024","author":"Porras","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02988-3","article-title":"Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis","volume":"21","author":"Prem","year":"2023","journal-title":"BMC Med"},{"issue":"67","key":"10.1016\/j.lanwpc.2026.101892_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jncimonographs\/lgae038","article-title":"Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling","volume":"2024","author":"Brisson","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101892_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2184605","article-title":"Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong","volume":"19","author":"Cheung","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101892_bib35","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.3802\/jgo.2024.35.e20","article-title":"Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program","volume":"35","author":"Choi","year":"2024","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02748-3","article-title":"Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis","volume":"21","author":"Choi","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.lanwpc.2026.101892_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127625","article-title":"Evaluating cost-effectiveness of 9-valent HPV vaccination for men who have sex with men by HIV status in Hong Kong","volume":"63","author":"You","year":"2025","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101892_bib40","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101892_bib43","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanwpc.2026.101892_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost\u2013effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101892_bib45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/14737167.2020.1812387","article-title":"Valuing health outcomes: developing better defaults based on health opportunity costs","volume":"21","author":"Ochalek","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101892_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/cid\/ciad205","article-title":"Human papillomavirus-associated anal cancer incidence and burden among US men, according to sexual orientation, human immunodeficiency virus status, and age","volume":"77","author":"Deshmukh","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkac088","article-title":"Prevalence and concordance of oral and genital HPV by sexual orientation among US men","volume":"7","author":"Sonawane","year":"2023","journal-title":"JNCI Cancer Spectr"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101892_bib48","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/cix159","article-title":"3rd. Prevalence and risk of penile human papillomavirus infection: evidence from The National Health and Nutrition Examination Survey 2013-2014","volume":"64","author":"Deshmukh","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101892_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/sti.2003.008854","article-title":"HIV related behaviours and attitudes among Chinese men who have sex with men in Hong Kong: a population based study","volume":"80","author":"Lau","year":"2004","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101892_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29460","article-title":"Prevalence of oral human papillomavirus infection among the general adult population in Hong Kong","volume":"96","author":"Ho","year":"2024","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-07460-7","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"22","author":"Husereau","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.lanwpc.2026.101892_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2019.100184","article-title":"HPV-FRAME: a consensus statement and quality framework for modelled evaluations of HPV-related cancer control","volume":"8","author":"Canfell","year":"2019","journal-title":"Papillomavirus Res"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101892_bib53","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jech-2020-216305","article-title":"Cost-effectiveness of extending the HPV vaccination to boys: a systematic review","volume":"75","author":"Linertova","year":"2021","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.lanwpc.2026.101892_bib54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12879-019-4108-y","article-title":"Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK","volume":"19","author":"Datta","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib55","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1080\/13696998.2023.2282912","article-title":"Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in Japan","volume":"26","author":"Palmer","year":"2023","journal-title":"J Med Econ"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101892_bib56","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.vaccine.2023.02.025","article-title":"Impact of including boys in the national school-based human papillomavirus vaccination programme in Singapore: a modelling-based cost-effectiveness analysis","volume":"41","author":"Wahab","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101892_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2557092","article-title":"Cost-effectiveness and epidemiological impact of gender-neutral vaccination against human papillomavirus in economically developed metropolises of Beijing, Shanghai, and Guangzhou, China","volume":"21","author":"Fu","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101892_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0333757","article-title":"Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan","volume":"20","author":"Chou","year":"2025","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101892_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019244","article-title":"Prevalence and risk factors of human papillomavirus (HPV) infection in southern Chinese women - a population-based study","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lanwpc.2026.101892_bib60","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1056\/NEJMoa2506765","article-title":"Noninferiority of one HPV vaccine dose to two doses","volume":"393","author":"Kreimer","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101892_bib61","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41591-023-02658-0","article-title":"Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results","volume":"29","author":"Barnabas","year":"2023","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101892_bib62","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1016\/S2214-109X(23)00586-7","article-title":"Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials","volume":"12","author":"Baisley","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"14","key":"10.1016\/j.lanwpc.2026.101892_bib63","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.vaccine.2022.02.067","article-title":"Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: an analysis in the United Kingdom","volume":"40","author":"Daniels","year":"2022","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.lanwpc.2026.101892_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17193179","article-title":"Cervical cancer screening in the HPV-vaccinated and digital era: reassessing strategies in light of artificial intelligence and evolving risk","volume":"17","author":"Galani","year":"2025","journal-title":"Cancers"},{"issue":"42","key":"10.1016\/j.lanwpc.2026.101892_bib65","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1016\/j.vaccine.2010.08.030","article-title":"Impact of vaccinating boys and men against HPV in the United States","volume":"28","author":"Elbasha","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101892_bib66","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0272989X18792283","article-title":"Nonidentifiability in model calibration and implications for medical decision making","volume":"38","author":"Alarid-Escudero","year":"2018","journal-title":"Med Decis Mak"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101892_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1016280411280","article-title":"A study of the STD\/AIDS related attitudes and behaviors of men who have sex with men in Hong Kong","volume":"31","author":"Lau","year":"2002","journal-title":"Arch Sex Behav"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101892_bib68","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/S2352-3018(21)00108-9","article-title":"Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies","volume":"8","author":"Wei","year":"2021","journal-title":"Lancet HIV"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:50:24Z","timestamp":1785883824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"alternative-id":["S2666606526000969"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101892","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness and health impact of gender-neutral and single-dose HPV vaccination in Hong Kong: a modeling analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101892"}}